Health Canada Authorizes Moderna's Omicron-Targeting Bivalent COVID-19 Booster VaccineAccesswire • 09/01/22
Is the Options Market Predicting a Spike in Moderna (MRNA) Stock?Zacks Investment Research • 09/01/22
EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of Moderna's Omicron-Targeting Bivalent Booster in the European UnionAccesswire • 09/01/22
Moderna Receives FDA Authorization for Emergency Use of Omicron-Targeting Bivalent COVID-19 Booster Vaccine for Adults 18 Years and OlderAccesswire • 08/31/22
Therapeutic Goods Administration Provisionally Approves Moderna's Omicron-Containing Bivalent Booster Candidate, MRNA-1273.214, For AustraliaAccesswire • 08/30/22
Is Moderna Stock A Buy As FDA Mulls Its Updated Covid Booster Shot?Investors Business Daily • 08/29/22
Swiss regulator grants temporary authorization for Moderna bivalent COVID booster for adults age 18 and olderMarket Watch • 08/29/22
Swissmedic Authorizes Moderna's Omicron-Targeting Bivalent Booster Candidate, MRNA-1273.214Accesswire • 08/29/22